Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS

Protection From Tariffs as an An umbrella that shields against import and export tariff taxes as a trade war storm increasing prices and straining supply chains as a business metaphor and a symbol for resilience in times of crisis and economic downturn.

Policy

NHS Mulls Greater Pharma Spending to Head Off Trump’s Tariffs: Report

The British proposal to increase support for pharma is “clearly positive,” according to analysts at Leerink, who noted that the NHS’ move will improve patient access to treatments.

October 10, 2025

2 min read

Tristan Manalac

Illustration showing a handshake, signaling cooperation, goodwill

Mergers & Acquisitions

Novo Strikes up to $5.2B Deal for Akero in Red-Hot MASH Space

Novo will add Akero’s efruxifermin to its MASH portfolio, which includes Wegovy after the GLP-1 gained an FDA nod in the indication earlier this year.

October 9, 2025

2 min read

Annalee Armstrong

2006 James Gathany Captured by James Gathany, Centers for Disease Control's biomedical photographer, this 2006 image depicted the exterior of the new "Tom Harkin Global Communications Center", otherwise known as Building 19, located on the organization's Roybal Campus in Atlanta, Georgia. The facility houses the CDC's Information Center/Library, auditoria and meeting halls, which are used to accommodate in-house staff meetings, and national/international conferences hosted by the CDC, and the National Center for Health Marketing's, Division of Creative Services, which includes a full service television broadcast facility. The exhibit area currently features the "Global Symphony", the first of several permanently installed exhibitions, and changing exhibitions that focus on a variety of public health topics. The exhibits in the Center are self-guided, and require no advance reservations. Additional curriculum-based exhibits and programming will be added in the future. Tom Harkin Global Communications Center Exhibit Area Centers for Disease Control and Prevention - 1600 Clifton Road, N.E., Atlanta, Georgia 30333 - Hours: Monday Friday, 9 am 5 pm, except for federal holidays Admission is free - Government-issue photo ID is required for entry. Please note that CDC is a working federal facility and as such does not provide public tours of its campus and laboratories. - For more information please call 404-639-0830.

Vaccines

ACIP Meeting Delayed Indefinitely; COVID-19 Vaccines Continue To Show Benefit in New Study

The CDC’s Advisory Committee on Immunization Practices was scheduled to convene Oct. 22 to 23, but this meeting has been postponed, with no new date specified. The delay comes as the VA published new research showing that COVID-19 shots prevented hospitalizations and death.

October 9, 2025

2 min read

Tristan Manalac

Illustration showing large scissors cutting employees in half

Layoffs

Ferring’s Shift to New Business Model Claims 500 Jobs Worldwide

The layoffs are part of the company’s shift to a new structure enabling cost efficiency for its new model.

October 9, 2025

2 min read

Tristan Manalac

Photo of female scientist using microscope

Job Trends

9 Companies Hiring in Oncology

Looking for a job in oncology? Check out the BioSpace list of nine companies hiring life sciences professionals like you.

October 9, 2025

2 min read

Angela Gabriel

People determined to be free, freedom and confinement vector art

Rare diseases

Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report

New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.

October 9, 2025

3 min read

Dan Samorodnitsky

Golden game piece with crown as a leader a group of golden game pieces - 3D illustration

Radiopharmaceuticals

Sanofi Comes for Novartis’ Radiopharma Crown With ‘Clinically Meaningful’ Pancreatic Tumor Data

Sanofi’s Orano Med-partnered radioligand therapy AlphaMedix achieved all primary efficacy endpoints, which included a measure of overall response rate, in the mid-stage ALPHAMEDIX-02 study.

October 8, 2025

2 min read

Annalee Armstrong

Modern design with a positive context, a handshake. Concept of help, support and harmony between adults. Modern art collage, trendy magazine style.

Mergers & acquisitions

Zenas Bets $2B+ in Autoimmune Agreement With Chinese Firm InnoCare

The centerpiece of the deal is orelabrutinib, a BTK inhibitor in late-stage development for multiple sclerosis that Biogen once paid $125 million for but abandoned after less than two years of testing.

October 8, 2025

2 min read

Tristan Manalac